Achieve Life Sciences Inc expected to post a loss of 36 cents a share - Earnings Preview

Achieve Life Sciences

05/08/2025 15:16

Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to  show no change in quarterly revenue when it reports  results on August 7 for the period ending June 30 2025

​LSEG's mean analyst estimate for Achieve Life Sciences Inc is for a loss of 36 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Achieve Life Sciences Inc is $14.00, about 81.6% above its last closing price of $2.58

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.38
-0.36
-0.37
Missed
-1.8
Dec. 31 2025
-0.36
-0.32
-0.36
Missed
-12.5
Sep. 30 2024
-0.28
-0.26
-0.36
Missed
-37.7​
Jun. 30 2024
-0.23
-0.23
-0.25
Missed
-7.9
​​Mar. 31 2024
-0.25
-0.24
-0.26
Missed
-6.6
Dec. 31 2023
-0.31
-0.31
-0.26
Beat
17.3​
Sep. 30 2023
-0.37
-0.38
-0.34
Beat
10.2
Jun. 30 2023
-0.41
-0.42
-0.43
Missed
-2

This summary was machine generated August 5 at 14:16 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)